Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Scientific Exceeds Wall Street’s Expectations In Q3

Oct 29 2020

• By Reed Miller

Sep 16, 2019 Fremont / CA / USA - Boston Scientific office buildings in Silicon Valley; Boston Scientific Corporation is a manufacturer of medical devices used in interventional medical specialties — • Source: shutterstock.com

Related Content

T2Bacteria Panel Wins CMS Approval For New Tech Add-On Payment

Aug 13 2019

FDA Approves Boston Scientific’s SYNERGY BP Stent For High Bleeding Risk Patients

Aug 13 2020

Abbott’s 3Q $8.9Bn Sales Beat Wall Street Consensus, Medtech Sales Up 3.4%

Oct 21 2020

Boston Scientific's TAVR Pipeline Delayed; FDA Approval Of Acurate neo2 Set For 2024

Oct 20 2020

J&J, Acutus And Boston Scientific Announce Plans For Pulsed Field AF-Ablation Technologies

Oct 05 2020

J&J Bounces Back In Q3, Led By Interventional Devices

Oct 14 2020

Boston Scientific Remains On Track For Return To Growth By 2021

Jul 29 2020

Related Companies

Boston Scientific Corporation

Additional Topics

Sales & Earnings Commercial Coronavirus COVID-19 Companies Research & Development Cardiovascular Cardiology Medical Device

More from R&D

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window